BeiGene, Ltd. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
BeiGene, Ltd. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2015 to Q2 2024.
  • BeiGene, Ltd. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $131M, a 26.5% increase year-over-year.
  • BeiGene, Ltd. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $408M, a 21.9% increase year-over-year.
  • BeiGene, Ltd. annual Share-based Payment Arrangement, Expense for 2023 was $368M, a 21.3% increase from 2022.
  • BeiGene, Ltd. annual Share-based Payment Arrangement, Expense for 2022 was $303M, a 25.9% increase from 2021.
  • BeiGene, Ltd. annual Share-based Payment Arrangement, Expense for 2021 was $241M, a 31.2% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $408M $131M +$27.4M +26.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $381M $88.7M +$13.3M +17.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $368M $92.8M +$14.6M +18.7% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-26
Q3 2023 $353M $96.1M +$17.9M +23% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $335M $103M +$22M +27.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 $313M $75.4M +$9.83M +15% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $303M $78.1M +$15.1M +24% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-26
Q3 2022 $288M $78.2M +$11.1M +16.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $277M $81.3M +$16.5M +25.5% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 $260M $65.6M +$19.7M +43% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $241M $63M +$13.6M +27.4% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-26
Q3 2021 $227M $67.1M +$16.8M +33.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $210M $64.8M +$19.3M +42.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $191M $45.8M +$7.58M +19.8% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $183M $49.5M +$11.1M +29% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-27
Q3 2020 $172M $50.3M +$13.5M +36.6% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $159M $45.5M +$12.9M +39.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $146M $38.3M +$11.9M +44.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $134M $38.3M +$12.4M +47.7% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $122M $36.8M +$11.7M +46.5% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $110M $32.6M +$14M +74.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $96.1M $26.4M +$9M +51.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $87.1M $26M +$9.5M +57.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-02-25
Q3 2018 $77.6M $25.1M +$11.8M +88.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $65.8M $18.6M +$11.6M +163% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $54.3M $17.4M +$11.4M +190% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $42.9M $16.5M +$12.5M +317% Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 $30.3M $13.3M +$10.5M +380% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 $19.8M $7.08M +$5.8M +451% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 $14M $5.99M +$3.38M +129% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
Q4 2016 $10.6M $3.95M +$1.78M +82.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $8.85M $2.78M -$2.04M -42.3% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $10.9M $1.29M +$375K +41.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $10.5M $2.61M +$300K +13% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 $10.2M $2.17M Oct 1, 2015 Dec 31, 2015 10-K 2018-02-28
Q3 2015 $4.82M Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-10
Q2 2015 $910K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-10
Q1 2015 $2.31M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.